Results 31 to 40 of about 400,521 (193)

Anastrozole-related acute hepatitis with autoimmune features: a case report [PDF]

open access: yes, 2011
Background Two cases of acute hepatitis occurring during treatment with anastrozole have previously been reported, but the underlying mechanisms of liver injury are still uncertain.
Alessandro Inno   +7 more
core   +2 more sources

Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)

open access: yesРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии, 2019
Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver injuries (DILI) are intended for all medical specialists, who treat such patients in their clinical practice.Key findings.
Vladimir T. Ivashkin   +8 more
doaj   +1 more source

Case series and review of Ayurvedic medication induced liver injury

open access: yesBMC Complementary Medicine and Therapies, 2021
Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002.
Christopher M. Karousatos   +3 more
doaj   +1 more source

Rational choice of hepatoprotectors for drug-induced liver injury

open access: yesGastroenterologìa, 2022
The article deals with a review of the current literature on the clinical use of hepatoprotectors in drug-induced liver injury. The literature was searched in Scopus, Web of Science, PubMed and other databases. Risk factors, pathogenetic mechanisms of li­
H.V. Osyodlo   +2 more
doaj   +1 more source

Treatment with gefitinib after erlotinib-induced liver injury: a case report [PDF]

open access: yes, 2011
INTRODUCTION: Gefitinib and erlotinib have minor differences in their chemical structures, and thus it remains unclear whether the hepatotoxicity induced by one compound is affected by the other.
Iida Tetsuya   +3 more
core   +2 more sources

Dietary Intake of Vegetables and Cooking Oil Was Associated With Drug-Induced Liver Injury During Tuberculosis Treatment: A Preliminary Cohort Study

open access: yesFrontiers in Nutrition, 2021
Background and Purpose: Drug-induced liver injury is challenging during tuberculosis treatment. There is no epidemiological data investigating the relation between dietary intake and the risk of drug-induced liver injury during tuberculosis treatment ...
Jinyu Wang   +6 more
doaj   +1 more source

Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment

open access: yesAnnals of Hepatology, 2019
Introduction and aim: Epidemiological information regarding drug-induced liver injury in some Latin American countries remains limited. Therefore, disease prevention and health promotion strategies are imperative to reduce drug-induced liver injuries and
Alejandra Cano-Paniagua   +3 more
doaj   +1 more source

Febuxostat-induced acute liver injury [PDF]

open access: yes, 2016
Febuxostat is a unique xanthine oxidase inhibitor that was approved for the prevention of gout in the United States in 2009. Unlike allopurinol, febuxostat is not a nucleoside analogue and has a higher specificity for xanthine oxidase. Although this drug
Matt Bohm   +3 more
core   +2 more sources

Insuficiência Hepática Aguda Induzida pela Trazodona e Diazepam [PDF]

open access: yes, 2016
Most antidepressant agents have the potential to cause liver injury, even at therapeutic doses. Nevertheless, drug-induced liver injury (DILI) from antidepressant agents is a rare event. There is no way to prevent idiopathic DILI, but the severity of the
Barroso, E   +5 more
core   +1 more source

Hepatitis E Virus Detection in Liver Tissue from Patients with Suspected Drug-Induced Liver Injury [PDF]

open access: yes, 2015
Hepatitis E virus (HEV) infection is increasingly recognized as a cause of acute hepatitis in the industrialized world. We aimed to determine the frequency of acute Hepatitis E virus (HEV) infection in cases of suspected drug-induced liver injury (DILI),
Achim Weber   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy